H
Heike L. Pahl
Researcher at University Medical Center Freiburg
Publications - 142
Citations - 11979
Heike L. Pahl is an academic researcher from University Medical Center Freiburg. The author has contributed to research in topics: Polycythemia vera & Transcription factor. The author has an hindex of 41, co-authored 140 publications receiving 11329 citations. Previous affiliations of Heike L. Pahl include University of Freiburg.
Papers
More filters
Journal ArticleDOI
Activators and target genes of Rel/NF-kappaB transcription factors.
TL;DR: It is argued that NF-κB functions more generally as a central regulator of stress responses and pairing stress responsiveness and anti-apoptotic pathways through the use of a common transcription factor may result in increased cell survival following stress insults.
Journal ArticleDOI
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.
TL;DR: The data suggest that such diverse stimuli as OA, TNF and PMA use the same kinase system to phosphorylate and thereby destabilize I kappa B‐alpha, leading to NF‐kappa B activation.
Journal ArticleDOI
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Véronique Imbert,Rudolf A. Rupec,Antonia Livolsi,Heike L. Pahl,E. Britta-Mareen Traenckner,Christoph Mueller-Dieckmann,Dariush Farahifar,Bernard Rossi,Patrick Auberger,Patrick A. Baeuerle,Jean-François Peyron +10 more
TL;DR: In this article, the authors reported an alternative mechanism of NF-κB activation by using tyrosine-phosphorylation of IκB-α in the presence of pervanadate.
Journal ArticleDOI
A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B.
TL;DR: It is shown that internal stress, caused by the accumulation of proteins in the endoplasmic reticulum, also induces NF‐kappa B DNA binding as well as kappa B‐dependent gene expression and participates in a novel ER‐nuclear signal transduction pathway distinct from the unfolded‐protein‐response described previously.
Journal ArticleDOI
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
Amy V. Jones,Andrew Chase,Richard T. Silver,David Oscier,Katerina Zoi,Y. Lynn Wang,Holger Cario,Heike L. Pahl,Andrew Collins,Andreas Reiter,Francis H. Grand,Nicholas C.P. Cross +11 more
TL;DR: It is reported here that JAK2V617F-associated disease is strongly associated with a specific constitutional Jak2 haplotype, designated 46/1, in all three disease entities compared to healthy controls and provides a model whereby a constitutional genetic factor is associated with an increased risk of acquiring a specific somatic mutation.